Navigation Links
Creabilis Appoints Catherine Moukheibir to its Board of Directors
Date:2/28/2013

LUXEMBOURG, February 28, 2013 /PRNewswire/ --

Creabilis SA, a late clinical stage European biotechnology company specialising in the development of treatments in dermatology, inflammation and pain, today announces that it has appointed Catherine Moukheibir to its Board of Directors.

Catherine has gained a wealth of experience in the pharmaceutical industry and finance in career spanning more than 30 years. She is currently Senior Advisor, Finance and Member of the Executive Committee at Innate Pharma, where she was responsible for a key licensing deal between the Company and Bristol-Myers Squibb. Prior to joining Innate Pharma, Catherine was Chief Financial Officer at Movetis, where she played a major role in the Company's IPO on Euronext Brussels and subsequent acquisition by Shire. Prior to joining Movetis, Catherine held a number of senior roles in investment banking including roles at Morgan Stanley and Salomon Smith Barney .

Catherine has held a number of other non-executive positions, including OctoPlus NV and is a partner at STJ Advisors in London. She has an MA and MBA from Yale University, USA.  

Catherine Moukheibir, commenting on her appointment, said: "I'm delighted to join the Creabilis board. The company has matured and now enters an important phase in its ambition to bring advanced science to dermatology, in particular through CT327, in the treatment of chronic pruritus. I look forward to working with the experienced Creabilis team to deliver value from CT327 and other products in its pipeline."

Dr Eliot Forster CEO of Creabilis said: "It is a pleasure to welcome Catherine to our Board of Directors. Her international financial background and successful transaction experience will significantly benefit the company as we seek to maximise the value of our lead product, CT327, in the treatment of chronic pr
'/>"/>

SOURCE Creabilis SA
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
2. Verenium Appoints Holger Liepmann To Its Board Of Directors
3. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
4. Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D
5. Avantium Appoints Jonathan Wolfson to its Supervisory Board
6. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
7. PCI Appoints Jose Solorio-Ruiz, MBA, Manager of West Coast Operations
8. Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
9. California Healthcare Institute Appoints Allergan CEO Chairman of the Board, Elects New Board Members
10. uniQure Appoints Philip Astley-Sparke President US
11. HealthEconomics.Com Appoints New Director of Information Technology and Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... New interactive learning forums ... leaders of the medical device industry at the ... expo, from June 18-20 in Philadelphia ... ) , These all-new MedTech ... practical presentations and implementable solutions on the most ...
(Date:5/17/2013)... Miami, FL (PRWEB) May 17, 2013 Men’s ... at La-roche Posay ) and has been known ... itself. Although some men may be far from puberty, other ... be clogging pores, causing breakouts, and threatening skin with unsightly ... with advice from Men’s Health on how to ...
(Date:5/17/2013)... WA (PRWEB) May 17, 2013 Tooth decay ... graders showing active signs of the disease. The World Health ... and nearly 100% of adults have cavities. What are the ... is showing a strong connection between the oral bacterial ... is this disease so rampant, yet it is also 100% ...
(Date:5/16/2013)... May 16, 2013 A new ... models, from Cole-Parmer is designed to meet the ... includes: , The new Cole-Parmer® MS-3400 Centrifuges ... in the lab. They ensure a powerful and ... specimen separation. Their standard four-place swinging buckets hold ...
Breaking Biology Technology:MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3Cole-Parmer Offers Enhanced Selection of Centrifuges 2
... Mass., July 23 NxStage Medical,Inc. (Nasdaq: ... today announced ongoing public access to current summary,information ... end-stage,renal-disease (ESRD) who undergo hemodialysis at home on ... to the conventional regimen of therapy,received three times ...
... WILMINGTON, Del., July 23 More than a ... AZN ) to inquire about the,company,s prescription savings ... pharmacists, according to a year-long survey of more ... percent of the patients who called,AstraZeneca,s information center ...
... Future, CAMBRIDGE, Mass., July 23 Genzyme Corporation,(Nasdaq: ... growth in the second,quarter, along with significant progress in ... to approximately $1.171 billion from,$933.4 million in last year,s ... areas of the business., GAAP net income was ...
Cached Biology Technology:NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population 2NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population 3NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population 4NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population 5AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs 2AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs 3Genzyme Reports Strong Second-Quarter Growth 2Genzyme Reports Strong Second-Quarter Growth 3Genzyme Reports Strong Second-Quarter Growth 4Genzyme Reports Strong Second-Quarter Growth 5Genzyme Reports Strong Second-Quarter Growth 6Genzyme Reports Strong Second-Quarter Growth 7Genzyme Reports Strong Second-Quarter Growth 8Genzyme Reports Strong Second-Quarter Growth 9Genzyme Reports Strong Second-Quarter Growth 10Genzyme Reports Strong Second-Quarter Growth 11Genzyme Reports Strong Second-Quarter Growth 12Genzyme Reports Strong Second-Quarter Growth 13Genzyme Reports Strong Second-Quarter Growth 14Genzyme Reports Strong Second-Quarter Growth 15Genzyme Reports Strong Second-Quarter Growth 16Genzyme Reports Strong Second-Quarter Growth 17
(Date:5/16/2013)... MD FASEB MARC (Maximizing Access to Research ... for The Society for Developmental Biology (SDB) 72nd ... 2013. These awards are meant to promote the ... groups into the mainstream of the basic science ... scientists at the SDB 2013 Annual Meeting. , ...
(Date:5/16/2013)... the stability of today,s largest ice sheets in Greenland and ... ago, for example when Earth was going through a ... high sea level due to ice sheet collapse at that ... if the world,s largest ice sheets collapsed in the past, ... progressively warming world. , However, a new groundbreaking study ...
(Date:5/16/2013)... -- Injectable nanoparticles developed at MIT may someday ... diabetes to constantly monitor their blood-sugar levels and ... designed to sense glucose levels in the body ... insulin, thereby replacing the function of pancreatic islet ... 1 diabetes. Ultimately, this type of system could ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3
... on algae, researchers at UT Southwestern Medical Center have found ... responsible for a cell's response to external signals. , Cilia ... sperm cells to make fertilization possible, line the nose to ... , With such a range of abilities, cilia serve ...
... someone say 'yes', coffee can help. Moderate amounts ... to which we can be persuaded, finds research published ... The Australian researchers from the University of Queensland found ... attend to, and agree with, persuasive arguments. , The ...
... cheaper, more effective liver cancer treatment, reports Lisa Richards ... over 2,800 people in the UK each year, of ... Surgery is the best option, but is unsuitable for ... chemotherapy. The American Cancer Society estimates that 18,510 new ...
Cached Biology News:'Cellular antennae' on algae give clues to how human cells receive signals 2
The Saturn 2200 answers your GC/MS questions with the CP-3800 GC and the 2000 Series Ion Trap MS! These components create a platform for the worlds most versatile GC and flexible MS. Both deliver une...
... The EZ DNA Methylation Kit uses ... method for DNA methylation analysis. The kit ... that takes place between cytosine and sodium ... The EZ DNA Methylation Kits innovative in-column ...
... intended for laboratory research use only. ... buffered formalin and embedded in paraffin. ... certified pathologists. Tissue cores were removed ... a new recipient paraffin block, in an ...
... intended for laboratory research use only. ... buffered formalin and embedded in paraffin. ... certified pathologists. Tissue cores were removed ... a new recipient paraffin block, in an ...
Biology Products: